Table 1 shows the age, BMI, infertility reasons, pregnancy rates, endometrial echogenicity thicknesses, IVF trials, serum FSH, LH, AMH, TSH, basal and transfer days E2, and P4 levels of the entire study group and females, who received different luteal phase support agents. The gene discussed is BRD2; the disease is Infertility.